Malaria: latest news

Malaria resources

  • Malaria

    Malaria is a tropical illness caused by parasites called plasmodia. Plasmodia depend on female mosquitoes for part of their life cycle. Most cases of malaria...

    From: HIV treatments directory

    Information level Level 4

Malaria features

Malaria news from aidsmap

More news

Malaria news selected from other sources

  • Malaria vaccine: Hopes rise for 2015 target after successful trials

    Vaccine that nearly halved cases among children aged between five and seven months could save millions in worst-hit countries.

    08 October 2013 | The Guardian
  • Insecticide-treated bed nets critical to global elimination of filariasis

    An international team of scientists have demonstrated that a simple, low-cost intervention holds the potential to eradicate a debilitating tropical disease that threatens nearly 1.4 billion people in more than six dozen countries.

    22 August 2013 | Eurekalert Inf Dis
  • Ugandan App for Pain-Free Malaria Test

    Matibabu uses a custom-made portable device called a matiscope, which is connected to a smartphone, to do a rapid diagnostic test. The user’s finger is inserted into the matiscope, and the application uses a red light to penetrate the skin and detect the red blood cells.

    13 August 2013 | Inter Press Service
  • Malaria and HIV Spike as Greece Cuts Healthcare Spending

    Greece's budgetary ax fell unduly hard on its healthcare sector, which was slated to grow at around 4 percent annually, but which has instead been jolted by a series of wage freezes, firings, and drug rationing programs.

    16 May 2013 | The Atlantic
  • Canada commits cash to Global Fund against AIDS, tuberculosis, malaria

    Canada’s Minister of International Co-operation Julian Fantino on Monday provided another $20 million to the Global Fund to support affordable medicines facilities for malaria.

    15 May 2013 | Toronto Star
  • Malaria Bednet Distribution in Sub-Saharan Africa Is About Half of What Is Needed

    Of the approximately 80 million insecticide-treated nets distributed through Global Fund–supported programmes in 2012, about 66 million (73%) went to sub-Saharan African countries. This is well below half the 150 million insecticide-treated nets that the World Health Organisation estimates are needed annually to protect all populations at risk of malaria in this region.

    09 April 2013 | Global Fund Observer
  • Follow-up study describes declining efficacy of malaria vaccine candidate over 4 years

    Long-term follow-up of a phase II study from KEMRI-Wellcome Trust Research Programme and Oxford University researchers in Kenya shows that the efficacy of a malaria vaccine candidate, RTS,S, wanes over time and varies with exposure to the malaria parasite.

    21 March 2013 | Eurekalert Inf Dis
  • Prezista (darunavir) label change - drug interaction information

    The FDA recently approved changes to the Prezista (darunavir) label to reflect drug interaction information with artemether/lumefantrine. The specific changes are outlined below.

    02 March 2013 | US Food and Drug Administration
  • US budget cuts could jeopardize development of life-saving tools against major killers

    Across-the-board cuts to US R&D programs could have a devastating impact on efforts to develop new drugs for tuberculosis and HIV/AIDS, the world's first malaria vaccine, and other vital global health products in development, according to a new report from a coalition of nonprofit groups focused on advancing innovation to save lives.

    27 February 2013 | Eurekalert Inf Dis
  • Research suggests malaria can be defeated without a globally led eradication program

    A researcher at the University of Southampton, working as part of a team from the UK and USA, believes the global eradication of malaria could be achieved by individual countries eliminating the disease within their own borders and coordinating efforts regionally. The team's findings have been published in the journal Science.

    27 February 2013 | Eurekalert Inf Dis
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.